The delaying of elective surgeries after COVID-19 infection decreases postoperative complications

Qudaisat, Ibraheem Y.; Toubasi, Ahmad A.; Obaid, Yazan Y.; Albustanji, Farah H; Al-Harasis, Sarah M.; Aloweidi, Abdelkarim

doi:10.1016/j.asjsur.2023.05.002

Cited by 3 publications

(1 citation statement)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This definition was informed by CDC research indicating that most patients recover from acute COVID-19 illness within four weeks, allowing us to capture the immediate and short-term effects of the infection on surgical and anesthesia outcomes 15 . Additionally, prior research have shown that patients undergoing surgery within four weeks of a COVID-19 diagnosis have a significantly higher risk of pulmonary complications and increased mortality rates 16 – 18 . Given these considerations and the practical challenges of subdividing our dataset into pre- and post-surgery infections, we adopted a 30-day window to comprehensively evaluate the impact of COVID-19 during this critical period.…”

Section: Discussionmentioning

confidence: 99%

Impact of perioperative COVID-19 infection on postoperative complication in cesarean section using Korean National Health insurance data

Kim,

Ahn,

Kim

et al. 2024

Sci Rep

View full text Add to dashboard Cite

The vulnerability during pregnancy has raised concerns about the potential impact of COVID-19 on obstetric anesthesia, an essential aspect of maternal care during cesarean section procedures. To evaluate the influence of COVID-19 infection on obstetric anesthesia during cesarean section, we analyzed the data from Korean National Health Insurance System (NHIS). This retrospective study utilized data from Korean NHIS. We included patients admitted with operation codes specific to cesarean section between January 1, 2020, and December 31, 2021. We classified patients into a COVID (+) group with a diagnosis code (U071) 30 days around surgery and a COVID (−) group without the code in the same period. The primary outcome was 30-day mortality that was defined as death within 30 days of admission due to any causes. Secondary outcomes were pulmonary complications (pneumonia, acute respiratory distress syndrome [ARDS], pulmonary thromboembolism [PTE], or unexpected postoperative mechanical ventilation), ICU admission, cardiac arrest, myocardial infarction [MI], other thromboembolic events, surgical site infection, sepsis, acute renal failure [ARF], and hepatic failure. Among 75,268 patients who underwent cesarean section, 107 had a COVID-19 diagnosis code, while 75,161 did not. After 1:4 propensity score matching (PSM), 535 patients were included in each group. 30-day mortality showed no significant differences between the two groups both before and after PSM. The COVID (+) group demonstrated significantly elevated rates of pneumonia, ARDS, PTE, and surgical site infection both before and after PSM. Hospital length of stay and admission costs were also significantly longer and higher, respectively, in the COVID (+) group before and after PSM. In subgroup analysis, no differences were observed in mortality and postoperative complications based on the anesthesia method after matching. COVID-19 infection is associated with increased rates of postoperative complications, including pneumonia, ARDS, PTE, surgical site infection, longer hospital stays, and increased admission costs, in patients who underwent cesarean section.

show abstract

Section: Discussionmentioning

confidence: 99%

Impact of perioperative COVID-19 infection on postoperative complication in cesarean section using Korean National Health insurance data

Kim,

Ahn,

Kim

et al. 2024

Sci Rep

View full text Add to dashboard Cite

show abstract

Lingering effects of COVID-19 in the care of perioperative patients

Jia,

Navare,

Hoyler

2024

Current Opinion in Anaesthesiology

View full text Add to dashboard Cite

Purpose of review Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), can lead to organ dysfunction and clinical symptoms beyond the acute infection phase. These effects may have significant implications for the management of perioperative patients. The purpose of this article is to provide a systems-based approach to the subacute and chronic effects of SARS-CoV-2 that are most relevant to anesthesiology practice. Recent findings In 2024, COVID-19 remains a concern for anesthesiologists due ongoing new infections, evolving viral strains, and relatively low rates of booster vaccination in the general population. A growing body of literature describes the post-COVID-19 syndrome in which patients experience symptoms more than 12 weeks after acute infection. Recent literature describes the lingering effects of SARS-CoV-2 infection on all major organ systems, including neurologic, pulmonary, cardiovascular, renal, hematologic, and musculoskeletal, and suggests an increased perioperative mortality risk in some populations. Summary This review offers anesthesiologists an organ system-based approach to patients with a history of COVID-19. Recognizing the long-term sequelae of SARS-CoV-2 infection can help anesthesiologists to better evaluate perioperative risk, anticipate clinical challenges, and thereby optimize patient care.

show abstract

The Impact of Postoperative COVID-19 Infection on 30-day Outcomes of Laparoscopic Cholecystectomy

Moulton,

Liu,

Miguel de Virgilio

et al. 2024

The American Surgeon™

View full text Add to dashboard Cite

Introduction: Preoperative Coronavirus Disease 2019 (COVID-19) infections are associated with postoperative adverse outcomes. However, there is limited data on the impact of postoperative COVID-19 infection on postoperative outcomes of common general surgery procedures. Objective: To evaluate the impact of postoperative COVID-19 diagnosis on laparoscopic cholecystectomy outcomes. Methods: Patients with symptomatic cholelithiasis, acute cholecystitis, or gallstone pancreatitis who underwent laparoscopic cholecystectomy with or without intraoperative cholangiogram were identified using the 2021 National Surgical Quality Improvement Program (NSQIP) database. Patients were categorized into two groups: patients with and without a postoperative COVID-19 diagnosis. Coarsened Exact Matching was used to match the groups based on preoperative risk factors, and outcomes were compared. Results: A total of 47,948 patients were included. In the aggregate cohort, 31% were male, and mean age was 50 years. Age, BMI, smoking, COPD, CHF, preoperative sepsis, and ASA class were significantly different between the two groups. After matching, there were no differences in characteristics. 30-day morbidity (OR = 2.7, 95% CI 1.4-5.1), pneumonia (OR = 5.0, 95% CI 1.7-15.0), DVT (OR = 8.22, 95% CI 1.0-66), reoperation (OR = 9.3, 95% CI 1.2-73.8), and readmission (OR = 4.8, 95% CI 2.3-10.1) continued to be significantly worse in the matched cohort. Conclusion: Postoperative COVID-19 infection was associated with worse outcomes after laparoscopic cholecystectomy. These findings suggest that even postoperative COVID-19 diagnosis increases the risk for adverse outcomes in patients recovering from laparoscopic cholecystectomy and may indicate that precautions should be taken and new COVID-19 infections even after surgery should be closely monitored.

show abstract

The delaying of elective surgeries after COVID-19 infection decreases postoperative complications

Cited by 3 publications

References 21 publications

Impact of perioperative COVID-19 infection on postoperative complication in cesarean section using Korean National Health insurance data

Impact of perioperative COVID-19 infection on postoperative complication in cesarean section using Korean National Health insurance data

Lingering effects of COVID-19 in the care of perioperative patients

The Impact of Postoperative COVID-19 Infection on 30-day Outcomes of Laparoscopic Cholecystectomy

Contact Info

Product

Resources

About